Once data from final analysis of phase III studies are available, Bharat Biotech will ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Once data from final analysis of phase III studies are available, Bharat Biotech will apply for full licensure for COVAXIN: Bharat Biotech'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)